Smith & Nephew plc has grown revenue 5.7% a year over three years and 6.2% a year over five, with earnings per share compounding at 41%. Revenue growth, 3-year annual rate: +5.7% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +6.2%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +41%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 11, FY2015 to FY2025, as filed.

SNNSmith & Nephew plc

HealthcareUSD

$29.30

$29.0552 weeks$37.81

Is it growing?

Is SNN growing?

Smith & Nephew plc has grown revenue 5.7% a year over three years and 6.2% a year over five, with earnings per share compounding at 41%.

+5.7%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +6.2%
Revenue growth, 5-year rate · +5.7% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +41%
Earnings per share, 3-year rate · revenue +5.7% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed